164 related articles for article (PubMed ID: 20657180)
1. Multiple tumor-suppressor genes on chromosome 3p contribute to head and neck squamous cell carcinoma tumorigenesis.
Lee DJ; Schönleben F; Banuchi VE; Qiu W; Close LG; Assaad AM; Su GH
Cancer Biol Ther; 2010 Oct; 10(7):689-93. PubMed ID: 20657180
[TBL] [Abstract][Full Text] [Related]
2. Genomic assessments of the frequent loss of heterozygosity region on 8p21.3-p22 in head and neck squamous cell carcinoma.
Ye H; Pungpravat N; Huang BL; Muzio LL; Mariggiò MA; Chen Z; Wong DT; Zhou X
Cancer Genet Cytogenet; 2007 Jul; 176(2):100-6. PubMed ID: 17656251
[TBL] [Abstract][Full Text] [Related]
3. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
Marescalco MS; Capizzi C; Condorelli DF; Barresi V
J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
[TBL] [Abstract][Full Text] [Related]
5. Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma.
Borkosky SS; Gunduz M; Nagatsuka H; Beder LB; Gunduz E; Ali MA; Rodriguez AP; Cilek MZ; Tominaga S; Yamanaka N; Shimizu K; Nagai N
J Cancer Res Clin Oncol; 2009 May; 135(5):703-13. PubMed ID: 18998165
[TBL] [Abstract][Full Text] [Related]
6. Microsatellite instability and loss of heterozygosity in squamous cell carcinoma of the head and neck.
Koy S; Plaschke J; Luksch H; Friedrich K; Kuhlisch E; Eckelt U; Martinez R
Head Neck; 2008 Aug; 30(8):1105-13. PubMed ID: 18615731
[TBL] [Abstract][Full Text] [Related]
7. Low microsatellite instability and high loss of heterozygosity rates indicate dominant role of the suppressor pathway in squamous cell carcinoma of head and neck and loss of heterozygosity of 11q14.3 correlates with tumor grade.
Glavac D; Volavsek M; Potocnik U; Ravnik-Glavac M; Gale N
Cancer Genet Cytogenet; 2003 Oct; 146(1):27-32. PubMed ID: 14499693
[TBL] [Abstract][Full Text] [Related]
8. Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.
Papadimitrakopoulou VA; Oh Y; El-Naggar A; Izzo J; Clayman G; Mao L
Clin Cancer Res; 1998 Mar; 4(3):539-44. PubMed ID: 9533520
[TBL] [Abstract][Full Text] [Related]
9. Identification of a candidate tumor suppressor gene RHOBTB1 located at a novel allelic loss region 10q21 in head and neck cancer.
Beder LB; Gunduz M; Ouchida M; Gunduz E; Sakai A; Fukushima K; Nagatsuka H; Ito S; Honjo N; Nishizaki K; Shimizu K
J Cancer Res Clin Oncol; 2006 Jan; 132(1):19-27. PubMed ID: 16170569
[TBL] [Abstract][Full Text] [Related]
10. Identification of mutations in the PYRIN-containing NLR genes (NLRP) in Head and Neck Squamous Cell Carcinoma.
Lei Y; Lui VW; Grandis JR; Egloff AM
PLoS One; 2014; 9(1):e85619. PubMed ID: 24465623
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 22q a frequent site of allele loss in head and neck carcinoma.
Poli-Frederico RC; Bergamo NA; Reis PP; Kowalski LP; Zielenska M; Squire JA; Rogatto SR
Head Neck; 2000 Sep; 22(6):585-90. PubMed ID: 10941160
[TBL] [Abstract][Full Text] [Related]
12. Fhit expression is absent or reduced in a subset of primary head and neck cancer.
Götte K; Hadaczek P; Coy JF; Wirtz HW; Riedel F; Neubauer J; Hörmann K
Anticancer Res; 2000; 20(2A):1057-60. PubMed ID: 10810397
[TBL] [Abstract][Full Text] [Related]
13. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.
Gunduz M; Ouchida M; Fukushima K; Ito S; Jitsumori Y; Nakashima T; Nagai N; Nishizaki K; Shimizu K
Oncogene; 2002 Jun; 21(28):4462-70. PubMed ID: 12080476
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of the candidate tumor suppressor gene ING1 in human head and neck tumors with 13q deletions.
Sanchez-Cespedes M; Okami K; Cairns P; Sidransky D
Genes Chromosomes Cancer; 2000 Mar; 27(3):319-22. PubMed ID: 10679922
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma.
Graveland AP; Golusinski PJ; Buijze M; Douma R; Sons N; Kuik DJ; Bloemena E; Leemans CR; Brakenhoff RH; Braakhuis BJ
Int J Cancer; 2011 Apr; 128(8):1852-9. PubMed ID: 20568113
[TBL] [Abstract][Full Text] [Related]
16. Detection of new PTEN/MMAC1 mutations in head and neck squamous cell carcinomas with loss of chromosome 10.
Poetsch M; Lorenz G; Kleist B
Cancer Genet Cytogenet; 2002 Jan; 132(1):20-4. PubMed ID: 11801303
[TBL] [Abstract][Full Text] [Related]
17. Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer.
Takebayashi S; Hickson A; Ogawa T; Jung KY; Mineta H; Ueda Y; Grénman R; Fisher SG; Carey TE
Genes Chromosomes Cancer; 2004 Oct; 41(2):145-54. PubMed ID: 15287027
[TBL] [Abstract][Full Text] [Related]
18. Tongue cancer patients have a high frequency of allelic loss at the von Hippel-Lindau gene and other loci on 3p.
Asakawa T; Esumi M; Endo S; Kida A; Ikeda M
Cancer; 2008 Feb; 112(3):527-34. PubMed ID: 18072267
[TBL] [Abstract][Full Text] [Related]
19. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
[TBL] [Abstract][Full Text] [Related]
20. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.
Qiu W; Schönleben F; Li X; Su GH
Cancer Lett; 2007 Jan; 245(1-2):163-70. PubMed ID: 16478646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
